Barclays
NH

Barclays’s NantHealth, Inc NH Stock Holding History

Barclays’s Portfolio NH Stock Details NH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-9
Closed – – 5297
2022
Q2 		$0 Sell
9
-282
-97% -$2.63K ﹤0.01% 5438
2022
Q1 		$4K Sell
291
-1,886
-87% -$24K ﹤0.01% 4744
2021
Q4 		$34K Buy
2,177
+1,444
+197% +$30.6K ﹤0.01% 3893
2021
Q3 		$17K Buy
733
+501
+216% +$15.1K ﹤0.01% 4432
2021
Q2 		$8K Sell
232
-1,272
-85% -$50.6K ﹤0.01% 4702
2021
Q1 		$72K Buy
1,504
+923
+159% +$53.5K ﹤0.01% 4117
2020
Q4 		$28K Sell
581
-244
-30% -$9.18K ﹤0.01% 4613
2020
Q3 		$29K Sell
825
-163
-16% -$9.19K ﹤0.01% 4822
2020
Q2 		$68K Buy
988
+985
+32,833% +$39.3K ﹤0.01% 4770
2020
Q1 		$0 Sell
3
-15
-83% -$359 ﹤0.01% 6602
2019
Q4 		$0 Buy
18
+11
+157% +$146 ﹤0.01% 6998
2019
Q3 		$0 Sell
7
-201
-97% -$1.79K ﹤0.01% 7292
2019
Q2 		$2K Sell
208
-1,148
-85% -$11.7K ﹤0.01% 6807
2019
Q1 		$18K Buy
1,356
+255
+23% +$2.96K ﹤0.01% 6399
2018
Q4 		$9K Buy
1,101
+321
+41% +$5.62K ﹤0.01% 6236
2018
Q3 		$18K Buy
780
+679
+672% +$25.8K ﹤0.01% 6501
2018
Q2 		$5K Sell
101
-246
-71% -$12.2K ﹤0.01% 6715
2018
Q1 		$17K Buy
347
+108
+45% +$5.42K ﹤0.01% 6499
2017
Q4 		$11K Buy
239
+119
+99% +$6.31K ﹤0.01% 6499
2017
Q3 		$7K Buy
120
+16
+15% +$937 ﹤0.01% 6307
2017
Q2 		$7K Buy
104
+81
+352% +$4.49K ﹤0.01% 6170
2017
Q1 		$2K Sell
23
-385
-94% -$42.9K ﹤0.01% 6511
2016
Q4 		$61K Buy
+408
New +$72.2K ﹤0.01% 5044

Other funds holding NH

HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Barclays's NH Position: Q3 2022 in Review

Barclays sold out of NantHealth, Inc (NH) in Q3 2022, closing a stake of 9 shares.

Barclays first reported a position in NH in Q4 2016 and held it in 23 quarters. The position peaked at $72K in Q1 2021. 38 funds tracked by Wall St. Rank hold NH as of Q3 2022.

  • Barclays reported no remaining NantHealth, Inc position as of Q3 2022 after selling out during the quarter.
  • Barclays sold 9 NantHealth, Inc shares in Q3 2022.
  • Barclays first reported a position in NantHealth, Inc in Q4 2016 and held it in 23 quarters.
  • Barclays's NantHealth, Inc position peaked at $72K in Q1 2021.
  • 38 funds tracked by Wall St. Rank held NantHealth, Inc as of Q3 2022.

Based on Barclays's 13F filing for Q3 2022, filed 3 Nov 2022.